KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teladoc Health (TDOC) Operating Expenses (2016 - 2025)

Teladoc Health (TDOC) has disclosed Operating Expenses for 12 consecutive years, with $678.3 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses fell 1.52% to $678.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.8 billion through Dec 2025, down 22.21% year-over-year, with the annual reading at $2.8 billion for FY2025, 22.21% down from the prior year.
  • Operating Expenses hit $678.3 million in Q4 2025 for Teladoc Health, roughly flat from $678.4 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $7.2 billion in Q1 2022 to a low of $538.4 million in Q1 2021.
  • Historically, Operating Expenses has averaged $1.4 billion across 5 years, with a median of $692.2 million in 2023.
  • Biggest five-year swings in Operating Expenses: soared 1243.86% in 2022 and later crashed 90.24% in 2023.
  • Year by year, Operating Expenses stood at $595.7 million in 2021, then surged by 647.61% to $4.5 billion in 2022, then tumbled by 84.38% to $695.6 million in 2023, then decreased by 0.99% to $688.7 million in 2024, then dropped by 1.52% to $678.3 million in 2025.
  • Business Quant data shows Operating Expenses for TDOC at $678.3 million in Q4 2025, $678.4 million in Q3 2025, and $686.3 million in Q2 2025.